Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012

被引:20
|
作者
Edwards, Hellen McKinnon [1 ]
Noer, Mette Calundann [2 ]
Sperling, Cecilie Dyg [3 ]
Nguyen-Nielsen, Mary [4 ,5 ]
Lundvall, Lene [2 ]
Christensen, Ib Jarle [6 ]
Hogdall, Claus [2 ]
机构
[1] Univ Copenhagen, Dept Obstet & Gynaecol, Herlev Hosp, Herlev Ringvej 75, DK-2730 Herlev, Denmark
[2] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Dept Gynecol, Copenhagen, Denmark
[3] Danish Canc Soc, Documentat & Qual, Copenhagen, Denmark
[4] Aarhus Univ Hosp Skejby, Dept Urol, Aarhus, Denmark
[5] Danish Canc Soc Res Ctr, Diet Genes & Environm, Copenhagen, Denmark
[6] Univ Copenhagen, Herlev Hosp, Dept Pathol, Herlev, Denmark
关键词
CO-MORBIDITY; POPULATION; STAGE; REGISTRY; AGE;
D O I
10.1080/0284186X.2016.1182641
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Ovarian cancer has a high mortality rate, especially in Denmark where mortality rates have been reported higher than in adjacent countries with similar demographics. This study therefore examined recent survival and mortality among Danish ovarian cancer patients over an 18-year study period.Methods: This nationwide registry-based observational study used data from the Danish Gynecology Cancer Database, Danish Pathology Registry, and Danish National Patient Registry. All patients with ovarian cancer diagnosed between 1995 and 2012 were included in the study. The data sources were linked via the patients' personal identification number and the analyses included data on cancer stage, age, survival, surgery status and comorbidity. The computed outcome measures were age-adjusted mortality rates and age-adjusted overall and relative survival rates for one and five years.Results: We identified 9972 patients diagnosed with ovarian cancer in the period 1995-2012. The absolute one-year mortality rate decreased from 42.8 (CI 40.3-45.6) in 1995-1999 to 28.3 (CI 25.9-30.9) in 2010-2012, and the five-year mortality rate decreased from 28.2 (CI 27.0-29.5) in 1995-1999 to 23.9 (CI 22.9-25.0) in 2005-2009. After stratification by age, comorbidity and cancer stage, the decrease in one-year mortality was most substantial in the 65-74 year old age group 41.1 (CI 38.8-43.5) to 26.5 (CI 24.4-28.7) and for stage III 39.1 (CI 35.1-43.6) to 22.9 (CI 19.9-26.5) and stage IV 91.3 (CI 80.8-103.2) to 41.9 (CI 35.5-49.5). For overall survival, we showed an increase in one-year survival from 68% (CI 66-69%) in 1995-1999 to 76% (CI 74-78%) in 2010-2012 and an increase in five-year survival from 33% (CI 32-35%) in 1995-1999 to 36% (CI 34-38%) in 2005-2009. Relative survival showed similar increases through the period.Conclusions: Ovarian cancer survival in Denmark has improved substantially from 1995 to 2012, bringing Denmark closer to the standards set by adjacent countries.
引用
收藏
页码:36 / 43
页数:8
相关论文
共 50 条
  • [1] Mortality and survival of lung cancer in Denmark: Results from the Danish Lung Cancer Group 2000-2012
    Jakobsen, Erik
    Rasmussen, Torben Riis
    Green, Anders
    ACTA ONCOLOGICA, 2016, 55 : 2 - 9
  • [2] Danish multidisciplinary cancer groups - DMCG.dk benchmarking consortium: Article series on cancer survival and mortality in Denmark 1995-2012
    Nguyen-Nielsen, Mary
    Borre, Michael
    ACTA ONCOLOGICA, 2016, 55 : 1 - 1
  • [3] Comorbidity and survival of Danish breast cancer patients from 1995 to 2005
    D P Cronin-Fenton
    M Nørgaard
    J Jacobsen
    J P Garne
    M Ewertz
    T L Lash
    H T Sørensen
    British Journal of Cancer, 2007, 96 : 1462 - 1468
  • [4] Comorbidity and survival of Danish breast cancer patients from 1995 to 2005
    Cronin-Fenton, D. P.
    Norgaard, M.
    Jacobsen, J.
    Garne, J. P.
    Ewertz, M.
    Lash, T. L.
    Sorensen, H. T.
    BRITISH JOURNAL OF CANCER, 2007, 96 (09) : 1462 - 1468
  • [5] RETROSPECTIVE COMPARISON OF RECTAL CANCER TREATMENT IN CHINA AND AUSTRALIA FROM 1995-2012
    Peng, Junjie
    Liu, Jia Jenny
    Daniels, Benjamin
    Firriolo, Joseph
    Laaksonen, Maarit A.
    Hawkins, Nicholas J.
    Meagher, Alan P.
    Hayes, Ian
    Croxford, Matthew
    Cai, Sanjun
    Ward, Robyn L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 106 - 106
  • [6] The impact of comorbidity on survival of Danish patients with prostate cancer from 1995 to 2004
    Lund, Lars
    Borre, Michael
    Jacobsen, Jacob
    Norgaard, Mette
    Sorensen, Henrik T.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 77 - 77
  • [7] History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium
    Minlikeeva, Albina N.
    Freudenheim, Jo L.
    Eng, Kevin H.
    Cannioto, Rikki A.
    Friel, Grace
    Szender, J. Brian
    Segal, Brahm
    Odunsi, Kunle
    Mayor, Paul
    Diergaarde, Brenda
    Zsiros, Emese
    Kelemen, Linda E.
    Kobel, Martin
    Steed, Helen
    deFazio, Anna
    Jordan, Susan J.
    Fasching, Peter A.
    Beckmann, Matthias W.
    Risch, Harvey A.
    Rossing, Mary Anne
    Doherty, Jennifer A.
    Chang-Claude, Jenny
    Goodman, Marc T.
    Doerk, Thilo
    Edwards, Robert
    Modugno, Francesmary
    Ness, Roberta B.
    Matsuo, Keitaro
    Mizuno, Mika
    Karlan, Beth Y.
    Goode, Ellen L.
    Kjaer, Susanne K.
    Hogdall, Estrid
    Schildkraut, Joellen M.
    Terry, Kathryn L.
    Cramer, Daniel W.
    Bandera, Elisa V.
    Paddock, Lisa E.
    Kiemeney, Lambertus A.
    Massuger, Leon F. A. G.
    Sutphen, Rebecca
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Menon, Usha
    Gayther, Simon A.
    Ramus, Susan J.
    Gentry-Maharaj, Aleksandra
    Pearce, Celeste L.
    Wu, Anna H.
    Kupryjanczyk, Jolanta
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (09) : 1470 - 1473
  • [8] P53 mutations in tissue from Danish ovarian cancer patients -: From the Danish "MALOVA" ovarian cancer study
    Hogdall, EVS
    Kjaer, SK
    Blaakaer, J
    Christensen, L
    Glud, E
    Vuust, J
    Hogdall, CK
    GYNECOLOGIC ONCOLOGY, 2006, 100 (01) : 76 - 82
  • [9] Trends in survival of patients with ovarian cancer in Saarland, Germany, 1976–1995
    Hermann Brenner
    Christa Stegmaier
    Hartwig Ziegler
    Journal of Cancer Research and Clinical Oncology, 1999, 125 : 109 - 113
  • [10] Improvements in breast cancer survival between 1995 and 2012 in Denmark: The importance of earlier diagnosis and adjuvant treatment
    Jensen, Maj-Britt
    Ejlertsen, Bent
    Mouridsen, Henning T.
    Christiansen, Peer
    ACTA ONCOLOGICA, 2016, 55 : 24 - 35